Revenue from continuing operations of $73.3 million, up 1.3% after excluding SETA revenue from same period last year GAAP EPS from continuing operations of ($0.01); normalization of tax provision would add $0.05 to GAAP EPS Adjusted EBITDA from continuing …
NASHVILLE, Tenn., Aug. 09, 2016 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading provider of surgical services, today announced results for the second quarter ended June 30, 2016. …
First Railcar of Isobutanol Shipped to Musket Corporation - Gevo to Host Conference Call Today at 4:30 p.m. EDT/2:30 MDT - Reports net loss per share of ($0.44) for the second quarter Reports non-GAAP adjusted net loss per share[1] of ($0.15) for the …
Consolidated net sales increased 36.7% and comparable(a) net sales increased 4.5% Consolidated income from operations increased 42.9% and comparable(a) income from operations increased 12.4% Consolidated basic net income per share decreased 42.1% to $1.68 …
PARK CITY, Utah, Aug. 09, 2016 (GLOBE NEWSWIRE) -- Skullcandy, Inc. (NASDAQ:SKUL) today announced financial results for the second quarter ended June 30, 2016. “We are pleased with our second quarter results. The market share gains achieved by our brands …
ENGLEWOOD, Colo., Aug. 09, 2016 (GLOBE NEWSWIRE) -- Ascent Capital Group, Inc. (“Ascent” or the “Company”) (Nasdaq:ASCMA) has reported results for the three and six months ended June 30, 2016. Ascent is a holding company that owns Monitronics International …
MCLEAN, Va., Aug. 09, 2016 (GLOBE NEWSWIRE) -- Gladstone Capital Corporation (NASDAQ:GLAD) (“Gladstone Capital”) announced that it has completed a $10 million 2nd lien debt investment in Merlin International, Inc. (“Merlin”). Headquartered in Vienna, VA, …
Total net revenues of $25.3 million, access rights renewal revenues were $14.8 million GAAP operating income of $4.2 million, Adjusted EBITDA of $7.1 million GAAP diluted EPS of $0.18, non-GAAP diluted EPS of $0.27 Generated $1.3 million in free cash flow …
Company Reports Double-Digit Quarterly Revenue Growth of 44% to $9.1 Million Second Quarter 2016 GAAP Net Loss of less than ($0.1) million; Non-GAAP Net Income of $2.1 million, or Nearly Double from Second Quarter 2015 Second Quarter Adjusted EBITDA Growth …
Fourth Fiscal Quarter Highlights Net Revenue of $241.7 million at high-end of guidance GAAP Operating margin of 4.2%; Non-GAAP Operating margin of 11.6% exceeded high-end of guidance GAAP diluted Net income per share of $0.23; Non-GAAP diluted Net income …
DANBURY, Conn., Aug. 09, 2016 (GLOBE NEWSWIRE) -- Ethan Allen (NYSE:ETH) becomes latest retailer to take up residence in New York City’s Flatiron District. Its new Design Center, located at 915 Broadway near East 21st street, is a stunning, nearly 12,000- …
CLEVELAND, Aug. 09, 2016 (GLOBE NEWSWIRE) -- Athersys, Inc. (Nasdaq:ATHX) today announced its financial results for the three months ended June 30, 2016. Highlights of the second quarter of 2016 include: Successful discussions with the Japanese …
CARLSBAD, Calif., Aug. 09, 2016 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ:SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today financial results for the second …
GAITHERSBURG, Md., Aug. 09, 2016 (GLOBE NEWSWIRE) -- OpGen, Inc. (NASDAQ:OPGN) today reported financial and operational results for the three and six months ended June 30, 2016. Highlights of the second quarter and recent weeks include: Achieved second …
SEATTLE and SOUTH SAN FRANCISCO, Aug. 09, 2016 (GLOBE NEWSWIRE) -- Immune Design (Nasdaq:IMDZ), a clinical-stage immunotherapy company focused on oncology, today reported financial results and a corporate update for the second quarter ended June 30, 2016. …
NEWARK, Calif., Aug. 09, 2016 (GLOBE NEWSWIRE) -- CymaBay Therapeutics, Inc. (NASDAQ:CBAY), a clinical-stage biopharmaceutical company focused on developing therapies to treat diseases with high unmet medical need, today provided recent corporate …
EMERYVILLE, Calif., Aug. 09, 2016 (GLOBE NEWSWIRE) -- Zogenix, Inc. (NASDAQ:ZGNX), a pharmaceutical company developing therapies for the treatment of orphan and central nervous system (CNS) disorders, today provided a corporate update and announced …
TUCSON, Ariz., Aug. 09, 2016 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM), a provider of instruments and reagents for molecular profiling applications, today reported financial results for the three and six month periods ended June 30 …
WEST LAFAYETTE, Ind., Aug. 09, 2016 (GLOBE NEWSWIRE) -- Endocyte, Inc. (NASDAQ:ECYT), a leader in developing targeted small molecule drug conjugates (SMDCs) and companion imaging agents for personalized therapy, today announced that the company’s …
Exclusive license to high-fidelity Cas9 and Cas9 PAM variants from Massachusetts General Hospital further advances leading genome editing platform Strategic partnership with Adverum to explore delivery of genomic medicines to treat range of genetic eye …
